Benjamin L. Ebert, President and CEO at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“It’s official!
We are thrilled to announce the name of our future inpatient cancer hospital: the Lavine Bekenstein Cancer Hospital at Dana-Farber.
Jeannie and Jonathan Lavine and Josh and Anita Bekenstein share a profound, decades-long commitment to advancing our mission to decrease the burden of cancer.
This naming adds renewed momentum toward a future in which the Lavine Bekenstein Cancer Hospital will enable Dana-Farber to reimagine what is possible in patient-centered adult oncology care for generations to come.
We are honored to thank Josh and Anita Bekenstein, and the Lavine family for their extraordinary leadership, generosity, and trust.”
Other articles about Dana-Farber on OncoDaily.